Full metadata record

DC Field Value Language
dc.contributor.authorNam, G.-H.-
dc.contributor.authorPahk, K.J.-
dc.contributor.authorJeon, S.-
dc.contributor.authorPark, H.-J.-
dc.contributor.authorKim, G.B.-
dc.contributor.authorOh, S.J.-
dc.contributor.authorKim, K.-
dc.contributor.authorKim, H.-
dc.contributor.authorYang, Y.-
dc.date.accessioned2024-01-19T17:32:59Z-
dc.date.available2024-01-19T17:32:59Z-
dc.date.created2022-01-28-
dc.date.issued2020-05-
dc.identifier.issn2366-3987-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/118644-
dc.description.abstractBoiling histotripsy (BH) is a completely non-invasive ultrasonic technique that can be used to mechanically destroy tumor tissues. Studies have shown that BH has biological effects on immune responses, but the mechanisms involved in the induction and enhancement of systemic anti-tumor immune responses after BH treatment are poorly understood. The present study therefore investigates the anti-tumor immune responses triggered by BH exposure in vivo. In a syngeneic tumor model, BH treatment results in more dendritic cell maturation and increased intra-tumoral infiltration of activated CD8+ T?cells compared to those observed after thermal high-intensity focused ultrasound exposure. The results clearly show that tumor antigens and danger signals released after BH exposure can lead to a sufficient anti-tumor immune response with antigen-presenting cell activation. In the 4T1 triple-negative breast cancer model, BH-induced mechanical ablation further enhances the therapeutic effect of immune checkpoint blockade, indicating a synergistic anti-tumor immune effect. In conclusion, the results presented in this study suggest that BH is a promising option for boosting anti-tumor immunity and can be beneficially combined with cancer immunotherapy. ? 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim-
dc.languageEnglish-
dc.publisherBlackwell Publishing Ltd-
dc.subjectcalreticulin-
dc.subjectCD3 antigen-
dc.subjectchemokine receptor CXCR4-
dc.subjectCXCL2 chemokine-
dc.subjectCXCL9 chemokine-
dc.subjectheat shock protein 70-
dc.subjecthigh mobility group B1 protein-
dc.subjectimmunological antineoplastic agent-
dc.subjectinterleukin 16-
dc.subjectinterleukin 1alpha-
dc.subjectinterleukin 1beta-
dc.subjectmacrophage inflammatory protein 1alpha-
dc.subjectmacrophage inflammatory protein 1beta-
dc.subjecttumor antigen-
dc.subjecttumor necrosis factor-
dc.subjectanimal cell-
dc.subjectanimal experiment-
dc.subjectanimal model-
dc.subjectanimal tissue-
dc.subjectantigen presenting cell-
dc.subjectantineoplastic activity-
dc.subjectArticle-
dc.subjectboiling histotripsy-
dc.subjectbone marrow derived macrophage-
dc.subjectcancer growth-
dc.subjectcancer immunotherapy-
dc.subjectcancer infiltration-
dc.subjectcancer inhibition-
dc.subjectcancer model-
dc.subjectcancer recurrence-
dc.subjectCD8+ T lymphocyte-
dc.subjectcell maturation-
dc.subjectcell viability-
dc.subjectcellular immunity-
dc.subjectcomparative study-
dc.subjectcontrolled study-
dc.subjectcytokine production-
dc.subjectdendritic cell-
dc.subjectenzyme linked immunosorbent assay-
dc.subjectflow cytometry-
dc.subjecthigh intensity focused ultrasound-
dc.subjectimmune response-
dc.subjectin vivo study-
dc.subjectmacrophage-
dc.subjectmale-
dc.subjectmouse-
dc.subjectnon invasive procedure-
dc.subjectnonhuman-
dc.subjectpriority journal-
dc.subjectqualitative analysis-
dc.subjectT lymphocyte activation-
dc.subjecttriple negative breast cancer-
dc.subjecttumor ablation-
dc.subjecttumor draining lymph node-
dc.subjecttumor immunity-
dc.subjectTUNEL assay-
dc.subjectultrasound therapy-
dc.titleInvestigation of the Potential Immunological Effects of Boiling Histotripsy for Cancer Treatment-
dc.typeArticle-
dc.identifier.doi10.1002/adtp.201900214-
dc.description.journalClass1-
dc.identifier.bibliographicCitationAdvanced Therapeutics, v.3, no.8-
dc.citation.titleAdvanced Therapeutics-
dc.citation.volume3-
dc.citation.number8-
dc.description.journalRegisteredClassscopus-
dc.identifier.scopusid2-s2.0-85103744447-
dc.type.docTypeArticle-
dc.subject.keywordPluscalreticulin-
dc.subject.keywordPlusCD3 antigen-
dc.subject.keywordPluschemokine receptor CXCR4-
dc.subject.keywordPlusCXCL2 chemokine-
dc.subject.keywordPlusCXCL9 chemokine-
dc.subject.keywordPlusheat shock protein 70-
dc.subject.keywordPlushigh mobility group B1 protein-
dc.subject.keywordPlusimmunological antineoplastic agent-
dc.subject.keywordPlusinterleukin 16-
dc.subject.keywordPlusinterleukin 1alpha-
dc.subject.keywordPlusinterleukin 1beta-
dc.subject.keywordPlusmacrophage inflammatory protein 1alpha-
dc.subject.keywordPlusmacrophage inflammatory protein 1beta-
dc.subject.keywordPlustumor antigen-
dc.subject.keywordPlustumor necrosis factor-
dc.subject.keywordPlusanimal cell-
dc.subject.keywordPlusanimal experiment-
dc.subject.keywordPlusanimal model-
dc.subject.keywordPlusanimal tissue-
dc.subject.keywordPlusantigen presenting cell-
dc.subject.keywordPlusantineoplastic activity-
dc.subject.keywordPlusArticle-
dc.subject.keywordPlusboiling histotripsy-
dc.subject.keywordPlusbone marrow derived macrophage-
dc.subject.keywordPluscancer growth-
dc.subject.keywordPluscancer immunotherapy-
dc.subject.keywordPluscancer infiltration-
dc.subject.keywordPluscancer inhibition-
dc.subject.keywordPluscancer model-
dc.subject.keywordPluscancer recurrence-
dc.subject.keywordPlusCD8+ T lymphocyte-
dc.subject.keywordPluscell maturation-
dc.subject.keywordPluscell viability-
dc.subject.keywordPluscellular immunity-
dc.subject.keywordPluscomparative study-
dc.subject.keywordPluscontrolled study-
dc.subject.keywordPluscytokine production-
dc.subject.keywordPlusdendritic cell-
dc.subject.keywordPlusenzyme linked immunosorbent assay-
dc.subject.keywordPlusflow cytometry-
dc.subject.keywordPlushigh intensity focused ultrasound-
dc.subject.keywordPlusimmune response-
dc.subject.keywordPlusin vivo study-
dc.subject.keywordPlusmacrophage-
dc.subject.keywordPlusmale-
dc.subject.keywordPlusmouse-
dc.subject.keywordPlusnon invasive procedure-
dc.subject.keywordPlusnonhuman-
dc.subject.keywordPluspriority journal-
dc.subject.keywordPlusqualitative analysis-
dc.subject.keywordPlusT lymphocyte activation-
dc.subject.keywordPlustriple negative breast cancer-
dc.subject.keywordPlustumor ablation-
dc.subject.keywordPlustumor draining lymph node-
dc.subject.keywordPlustumor immunity-
dc.subject.keywordPlusTUNEL assay-
dc.subject.keywordPlusultrasound therapy-
dc.subject.keywordAuthorantigen-presenting cells-
dc.subject.keywordAuthorboiling histotripsy-
dc.subject.keywordAuthorcancer immunotherapy-
dc.subject.keywordAuthorhigh-intensity focused ultrasound-
dc.subject.keywordAuthorimmune checkpoint blockade-
Appears in Collections:
KIST Article > 2020
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE